FIBRINOGEN ANOMALIES AND DISEASE - A CLINICAL UPDATE

被引:27
作者
GALANAKIS, DK [1 ]
机构
[1] SUNY STONY BROOK,SCH MED,DEPT PATHOL,STONY BROOK,NY 11794
关键词
D O I
10.1016/S0889-8588(18)30303-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1171 / 1187
页数:17
相关论文
共 104 条
[1]  
ALMONDHIRY H, 1987, J LAB CLIN MED, V110, P726
[2]   FIBRINOGEN GIESSEN-I - A CONGENITAL HOMOZYGOUSLY EXPRESSED DYSFIBRINOGENEMIA WITH A-ALPHA 16-ARG-] HIS SUBSTITUTION [J].
ALVING, BM ;
HENSCHEN, AH .
AMERICAN JOURNAL OF HEMATOLOGY, 1987, 25 (04) :479-482
[3]  
BELITZER WA, 1952, BIOKHIMIYA, V17, P676
[4]  
BLOMBACK B, 1988, FIBRINOGEN, V3, P263
[5]  
BOWIE EJW, 1963, J LAB CLIN MED, V62, P416
[6]  
BUDZYNSK.AZ, 1974, J BIOL CHEM, V249, P2294
[7]  
BUDZYNSKI AZ, 1974, BLOOD, V44, P950
[8]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[9]   INHIBITION OF FIBRIN MONOMER POLYMERIZATION BY LAMBDA MYELOMA GLOBULINS [J].
COLEMAN, M ;
WEKSLER, ME ;
VIGLIANO, EM ;
NACHMAN, RL .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 39 (02) :210-&
[10]  
CONLON CL, 1978, 17 P C INT SOC HEM, P937